Private Market View

Hemerion Therapeutics

Villeneuve-d'Ascq, France · Founded 2020 · Privately Held (backing)

Last price · $/share
Implied valuation
$26.2M
Total raised
$14.2M
Last round
What is Hemerion Therapeutics worth?
$26.2Mlast known valuation
Free account
See the evidence behind this price
  • ·The complete investor list — 9 names
  • ·Watchlist + deal alerts for Hemerion Therapeutics
  • ·The full record, as it builds
Create free account
No card required

Funding history

No rounds on record

No funding rounds for Hemerion Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

How Hemerion Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Hemerion Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

What is Hemerion Therapeutics worth?
Hemerion Therapeutics's last known valuation is $26.2M.
How much has Hemerion Therapeutics raised?
Hemerion Therapeutics has raised $14.2M in total funding across its recorded rounds.